TechFlow news, October 2: According to official announcements, Injective has launched an on-chain Pre-IPO market designed to enable global investors to trade synthetic assets of major private companies, including OpenAI. This new product allows users to gain up to 5x leveraged exposure to private company valuations directly via Injective.
Add to Favorites
Share to Social Media
7x24h News
11/19, 00:57
Exclusive
Commonwealth Bank of Australia Invests in Its Own Digital Infrastructure to Advance AI
11/19, 00:56
Exclusive
Morgan Stanley cuts Tencent price target to HKD 480, maintains overweight rating.





